Skin transplantation. The donor was sacrificed according to the Animal Health Service recommendations, the base of the ear was washed with alcohol and after excising the ear, the skin was harvested and placed in sterile PBS on ice. Recipient mouse was anesthetized with a mix of Xylacin-Ketamine (10 mg/kg and 80 mg/kg respectively) intraperitoneally administrated. The dorsal back of the mouse was then shaved and washed with alcohol, skin was tent with a rat-tooth forceps and cut below for making a ~1 cm incision. Donor skin was placed on the injury, removing excess of PBS and the excess of donor skin. A sterile bandage was placed to protect the skin graft and secured with a single 2-0 silk suture. Mice were then placed in a clean sterile cage and monitored daily. Transplantations were made using C57BL/6 wild-type, Nlrp3
-/-, Casp1/11 -/-, P2rx7 -/-Il1r1 -/-or Il18 -/-(all in C57BL/6 background) mice as receptors. BALB/c mice were used as donors in allogeneic transplantations, while C57BL/6 were used as donors in isogeneic transplantations. Alternatively, BALB/c mice were used as recipient and allogeneic skin from C57BL/6 or P2rx7 -/-(in C57BL/6 background) was used as donors when indicated in the text. Wild-type animals were treated with A438079 (100 µmol/kg) on the skin wound at the surgical moment and in some experiments then treated intraperitoneally daily. Some P2rx7 -/-mice receiving allogeneic transplants were supplemented with 10 6 bone marrow differentiated macrophages (BMDM) under the transplanted skin the same day the transplant was performed.
Reagents and antibodies. D-Luciferin was obtained from Perkin-Elmer laboratories. Mitomycin and apyrase were from Sigma-Aldrich. The specific P2X7 receptor antagonist A438079 was from Tocris. ACK lysing buffer (Lonza) and collagenase A (Roche). For the anaesthetic procedure, mice were treated with Xilacin (Xilagesic ® Calier Laboratories) and with Ketamin (Ketolar ® Pfizer Laboratories). Isoflorane was obtained from Inibsa laboratories. Commercial neutral buffered 4% formalin (Panreac Química) was used for fixation of the tissue samples. For histopathological staining, commercial Harris hematoxylin (acidified), alcoholic eosin and xylene substitute (Clear Rite) were purchased from Thermo and absolute ethanol from VWR. For immunohistochemical staining, high pH demasking antigen, washing buffer, antibody diluent and 3-3´-Diaminobencidine (DAB) solutions were purchased from Dako. Primary antibodies used were: polyclonal rabbit-anti CD3 (#A0452, Dako) and monoclonal rat anti-F4/80 clone CL:A3-1 (#MCA49RT, AbdSerotec). For CD3-lymphocyte immunostaining, a labelled polymer commercial system was used (EnVision System, Dako). For F4/80 immunostaining, Polyclonal biotinylated rabbit anti-rat antibody was used (#E0468, Dako), and an avidinperoxidase complex system (Vectastain Elite ABC kit) from Vector Labs.
Cells and treatments. BMDM were obtained from wild-type or P2rx7
-/-mice using 25% of L-cell conditioned media as previously described (Baroja-Mazo et al., 2014) . pmeLuc cells were maintained in DMEM:F12 (1:1) supplemented with 10% foetal calf serum (FCS), 2mM glutamax 1% and G418 0.2 mg/ml (Acros Organic). Extracellular ATP was measured in supernatants of BMDM after exposition to complete C57BL/6 or Balb/c ear skin or 10 mg/ml of OVA (Sigma), using the ATP Bioluminescent Assay kit from Sigma-Aldrich and following manufacturer's instructions. BMDMs incubated or not for 2 h with 10 mg/ml of OVA or 1 m g/ml of LPS were incubated for 5 min with 25 m M of YoPro-1 (Life Technologies) and then stimulated with ATP (3 mM). Fluorescence of DNA-bound Yo-Pro-1 was measured in a Synergy Mx plate reader (BioTek) every 30 sec at 485±9 nm excitation and 515±9 nm emission. One-way mixed lymphocytic reaction was performed with 2 x 10 5 lymphocytes obtained from axillar nodes 3 or 7 days after transplantation. They were cultured in the presence of 2 x 10 5 mitomycin treated-splenocytes from C57BL/6 or BALB/c for 4 days in RPMI supplemented with 10% FCS, 2 mM L-glutamine (Life Technologies), 1 mM sodium pyruvate (Sigma-Aldrich), Penicillin/Streptomycin (50 U/ml and 5000 µg/ml respectively), 10 mM HEPES, 1x non-essential amino acid cocktail (Sigma-Aldrich) and 50 m M 2-mercaptoethanol (SigmaAldrich).
ATP and liver enzymes determination. Concentration of ATP in the plasma of human samples or supernatants of stimulated BMDMs was determined by luminescence by means of the ATP assay mix (Sigma-Aldrich) following the manufacturer's instructions. Liver enzymes (AST, ALT, alkaline phosphatase and GGT) were determined in the plasma of human samples a COBAS® 8000 modular analyser series (Roche).
Humoral allogeneic response. Determination of the different IgGs titter against allogeneic antigens was performed incubating serum from transplanted mice (day 7 post-transplant) with thymocytes from mice with the same haplotype than the graft. After 30 min of incubation, cells were washed and then incubated with anti-IgG1, IgG2a, IgG2b and IgG3 biotinylated antibodies in separate tubes. At the end, cells were incubated with streptavidin-FITC and subjected to flow cytometry as explained above.
Quantitative reverse transcriptase-PCR analysis. Detailed methods used for qRT-PCR have been described previously (López-Castejón et al., 2011) . Briefly, transplanted skin was collected from mice at 3 and 7 days after transplantation and tissue was homogenised in RLT buffer (Qiagen) using Omni Tip TM plastic generator probes (Omni). RNA was purified using the RNAesy kit (Qiagen) according to manufacturer's recommendations and quantified on a nanodrop 2000 (Thermo Fisher). Reverse transcription was realized using iScript TM cDNA Synthesis kit (BioRad). qPCR was performed in an iQ TM 5 Real Time PCR detection System (BioRad) with a SYBR Green mix (Takara) and primers used were obtained from Qiagen (Quantitec primer Assay, Qiagen). The presented relative gene expression levels were calculated using the 2 -ΔΔCt method normalizing to Gapdh expression as endogenous control and the fold increase in expression was relative to healthy mice skin. -/-mice (n= 20 different field of view from 3 independent transplants). Right: representative immunostained sections for F4/80, scale bar 50 µm. (E) Extracellular ATP detected in allografts with the pmeLuc biosensor 3 days after transplantation in wild-type BALB/c recipient mice with C57BL/6 donor skin from wild-type or P2X7-deficient mice as indicated. Top, luciferase signal of one representative mouse per group. Bottom, average radiance (p/s/cm2/sr) of n= 4 to 6 transplants. Data are presented as mean ± sem from the indicated number of independent experiments. ns, no significant difference (p> 0.05); ANOVA with Bonferroni's post-test for C and and t-Student for D,E. For C-E data are represented as mean ± SEM. -/-as recipient and C57BL/6 (syngeneic) or BALB/c (allogeneic) skin as donor. (B) Relative gene expression for Il12b in grafts 3 or 7 days after transplantation using C57BL/6 wild-type or Il1r1 -/-as recipient and BALB/c skin as donor (n= 4-5). (C) IFN-g ELISA produced by axillar lymph node lymphocytes collected 7 days after transplantation and subjected to mixed lymphocytic reaction (MLR) with allogeneic splenocytes (n= 4-5). (D) Representative images of haematoxylin and eosin stained skin grafts, using C57BL/6 Il1r1 -/-as recipient and BALB/c skin as donor; scale bar 50 µm. (E) Representative picture of CD8 immunostaining on allogeneic skin grafts 7 days after transplantation BALB/c skin in C57BL/6 wild-type, Il18 
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